BRPI0617511A8 - conjugado de peptídeo-imunoglobulina - Google Patents

conjugado de peptídeo-imunoglobulina

Info

Publication number
BRPI0617511A8
BRPI0617511A8 BRPI0617511A BRPI0617511A BRPI0617511A8 BR PI0617511 A8 BRPI0617511 A8 BR PI0617511A8 BR PI0617511 A BRPI0617511 A BR PI0617511A BR PI0617511 A BRPI0617511 A BR PI0617511A BR PI0617511 A8 BRPI0617511 A8 BR PI0617511A8
Authority
BR
Brazil
Prior art keywords
peptide
immunoglobulin conjugate
immunoglobulin
conjugate
Prior art date
Application number
BRPI0617511A
Other languages
English (en)
Inventor
Kopetzki Erhard
Schumacher Ralf
Sankuratri Suryanarayana
Fischer Stephan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35809600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0617511(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0617511A2 publication Critical patent/BRPI0617511A2/pt
Publication of BRPI0617511A8 publication Critical patent/BRPI0617511A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0617511A 2005-10-21 2006-10-19 conjugado de peptídeo-imunoglobulina BRPI0617511A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05023002 2005-10-21
PCT/EP2006/010061 WO2007045463A1 (en) 2005-10-21 2006-10-19 A peptide-immunoglobulin-conjugate

Publications (2)

Publication Number Publication Date
BRPI0617511A2 BRPI0617511A2 (pt) 2015-07-07
BRPI0617511A8 true BRPI0617511A8 (pt) 2018-04-24

Family

ID=35809600

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0617511A BRPI0617511A8 (pt) 2005-10-21 2006-10-19 conjugado de peptídeo-imunoglobulina

Country Status (13)

Country Link
US (1) US20070148180A1 (pt)
EP (1) EP1940882A1 (pt)
JP (1) JP2009512655A (pt)
KR (1) KR20080070014A (pt)
CN (1) CN101291956A (pt)
AR (1) AR056137A1 (pt)
AU (1) AU2006303438A1 (pt)
BR (1) BRPI0617511A8 (pt)
CA (1) CA2625332A1 (pt)
IL (1) IL190552A0 (pt)
NO (1) NO20081704L (pt)
TW (1) TW200722436A (pt)
WO (1) WO2007045463A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
PE20081140A1 (es) 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
AU2008262490B2 (en) 2007-05-22 2011-11-17 Amgen Inc. Compositions and methods for producing bioactive fusion proteins
EP2592147A1 (en) 2007-10-12 2013-05-15 F. Hoffmann-La Roche AG Protein expression from multiple nucleic acids
MX347291B (es) 2009-03-20 2017-04-17 Amgen Inc Inmunoglobulinas portadoras y usos de las mismas.
CA2781532A1 (en) 2009-11-20 2011-05-26 Amgen Inc. Anti-orai1 antigen binding protein that binds the second extracellular loop of orai1
EP2603794A1 (en) 2010-08-10 2013-06-19 Amgen Inc. Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
WO2012040518A2 (en) * 2010-09-22 2012-03-29 Amgen Inc. Carrier immunoglobulins and uses thereof
SG191993A1 (en) 2011-01-18 2013-08-30 Amgen Inc Nav1.7 knockout mice and uses thereof
CN104066845A (zh) * 2011-12-15 2014-09-24 皇家学术促进会/麦吉尔大学 可溶性IGF受体Fc融合蛋白和其用途
CA2864702A1 (en) 2012-02-22 2013-08-29 Amgen Inc. Autologous mammalian models derived from induced pluripotent stem cells and related methods
MX2017004769A (es) 2014-10-15 2017-10-16 Amgen Inc Elementos promotores y reguladores para mejorar la expresion de genes heterologos en celulas hospederas.
EP3568411B1 (en) 2017-01-13 2024-03-06 Pietro P. Sanna Methods and compositions for treating hpa hyperactivity
JP2020535199A (ja) * 2017-09-29 2020-12-03 ハンミ ファーマシューティカル カンパニー リミテッド 効力が向上した持続性タンパク質結合体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567584A (en) * 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
ES2252732T3 (es) * 1992-05-26 2006-05-16 Immunex Corporation Nueva citoquina que une cd30.
US6620413B1 (en) * 1995-12-27 2003-09-16 Genentech, Inc. OB protein-polymer chimeras
EP0912738B1 (en) * 1996-05-22 2008-07-30 Viventia Biotech Inc. Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
AU2001265417A1 (en) * 2000-06-05 2002-04-08 University Of Tennessee Corporation Compositions and methods for the endocytic presentation of immunosuppressive factors
US20030077826A1 (en) * 2001-02-02 2003-04-24 Lena Edelman Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
BRPI0418304A (pt) * 2004-01-07 2007-05-02 Trimeris Inc peptìdeo sintético, uso do mesmo, composição farmacêutica, seqüência de nucleotìdeos, e, métodos para inibição da transmissão de hiv para uma célula, para inibição da fusão de hiv, e para tratamento de um indivìduo infectado com hiv

Also Published As

Publication number Publication date
WO2007045463A1 (en) 2007-04-26
BRPI0617511A2 (pt) 2015-07-07
CA2625332A1 (en) 2007-04-26
CN101291956A (zh) 2008-10-22
JP2009512655A (ja) 2009-03-26
EP1940882A1 (en) 2008-07-09
US20070148180A1 (en) 2007-06-28
AU2006303438A1 (en) 2007-04-26
KR20080070014A (ko) 2008-07-29
NO20081704L (no) 2008-06-05
AR056137A1 (es) 2007-09-19
TW200722436A (en) 2007-06-16
IL190552A0 (en) 2008-11-03

Similar Documents

Publication Publication Date Title
BRPI0617511A8 (pt) conjugado de peptídeo-imunoglobulina
DK1928882T3 (da) (s)-n-methylnaltrexon
ATE408603T1 (de) Pyrazolylcarboxanilide
CR9974A (es) Gavión
DE502006003394D1 (de) Lehnenklappung
DE502006008475D1 (de) Wasserpumpenflügelrad
DK1943406T3 (da) Byggeelement
DE502006005667D1 (de) Gelenklager
ATE549324T1 (de) Tetrahydrobenzoxazine
DE502006006857D1 (de) Wingungserregern
DE502006005768D1 (de) Hydrolysestabilisatorformulierungen
DE602005021060D1 (de) Notrufleitweglenkung
DE502006001397D1 (de) Lagerbuchse
DE502006006589D1 (de) Teils
ATE485368T1 (de) Hiv - impfung
DE502006004302D1 (de) Verschlusskappe
DE502006003147D1 (de) Verbundgußplatte
DE502006001004D1 (de) Hydrolager
DE102005052834B8 (de) Punktschweißklebverbindung
DE502006003210D1 (de) Nohydrogenpolysiloxanen
AT501523A3 (de) Estrich
DK1960510T3 (da) Ammoniakspecifik 5'-xmp-aminasemutant
DE602006007836D1 (de) Kontrastmittel
DE102006033170A8 (de) Einfassnähmaschine
DE502006006199D1 (de) Rzuständen

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: APRESENTE NOVAS VIAS DE DESENHOS, SEM CORES, CONFORME DETERMINA O ITEM 15.1.4.1 (B) DO AN NO 127/1997.

B12C Appeal against dismissal [chapter 12.3 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]